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Background:  Encephalitis  is  a severe  neurological  syndrome  usually  caused  by  viruses.  Despite  signiﬁcant
progress  in  diagnostic  techniques,  the  causative  agent  remains  unidentiﬁed  in the  majority  of  cases.  The
aim of  the  present  study  was  to test  an alternative  approach  for the  detection  of  putative  pathogens  in
encephalitis  using  next-generation  sequencing  (NGS).
Methods:  RNA  was  extracted  from  cerebrospinal  ﬂuid  (CSF)  from  a 60-year-old  male patient  with
encephalitis  and  subjected  to  isothermal  linear  nucleic  acid ampliﬁcation  (Ribo-SPIA,  NuGen)  followed
by  next-generation  sequencing  using  MiSeq  (Illumina)  system  and  metagenomics  data  analysis.
Results:  The  sequencing  run  yielded  1,578,856  reads  overall  and  2579  reads  matched  human  herpesvirus
I  (HHV-1)  genome;  the  presence  of  this  pathogen  in  CSF  was  conﬁrmed  by  speciﬁc  PCR.  In  subsequent
experiments  we  found  that  the  DNAse  I treatment,  while  lowering  the  background  of  host-derived
sequences,  lowered  the  number  of detectable  HHV-1  sequences  by  a factor  of 4.  Furthermore,  we  found
that  the  routine  extraction  of  total  RNA  by  the Chomczynski  method  could  be used for  identiﬁcation  of
both  DNA  and  RNA pathogens  in  typical  clinical  settings,  as  it  results  in retention  of a signiﬁcant  amount
of  DNA.
Conclusion:  In  summary,  it seems  that  NGS  preceded  by  nucleic  acid ampliﬁcation  could  supplement
 methcurrently  used  diagnostic
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Encephalitis is a severe neurological syndrome, which may  be
caused by viruses as well as bacteria, fungi and parasites (Chaudhuri
and Kennedy, 2002; Glaser et al., 2006; Solomon et al., 2007).
Diagnostic procedures include serological testing for speciﬁc anti-
bodies in blood and cerebrospinal ﬂuid (CSF), detection of causative
pathogens by molecular methods in CSF and blood, and occasionally
even pathogen culture (Solomon et al., 2007). Correct diagnosis is
facilitated by epidemiological data and clinical symptoms, routine
CSF analysis and neuroimaging studies (Chaudhuri and Kennedy,
2002; Solomon et al., 2007). Surprisingly, in a large proportion
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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f cases the exact etiology of encephalitis remains unknown. For
xample, The Californian Encephalitis Project, which included 1570
atients, failed to identify cause of encephalitis in 63% of patients
Glaser et al., 2006), while in a French study the etiology of
ncephalitis remained unknown in 80% of cases (Mailles et al.,
007). However, identiﬁcation of causative agents is crucial for the
orrect diagnosis and may  be necessary for the timely introduction
f speciﬁc treatment (Studahl et al., 2013).
The high rate of cases with unclear etiology is partly due to
he limited sensitivity and speciﬁcity of currently used diagnos-
ic assays, but also to the suboptimal time of sample collection,
ince viral pathogens may  be detectable only transiently (Glaser
t al., 2006; Studahl et al., 2013). Moreover, a large and still
xpanding number of pathogens reported to be capable of causing
ncephalitis makes speciﬁc diagnosis challenging due to the sheer
cope of required testing (Kennedy, 2005). A recently developed
ext-generation sequencing (NGS) technique offers a potential
reakthrough in the diagnostic process of encephalitis by eliminat-
ng the need for testing of individual pathogens. High-throughput
equencing has already established a ﬁrm foothold in the area of
icrobiology as it has been successfully employed for pathogen
etection (including novel microorganisms), analysis of genetic
volution and diversity, as well as for the determination of drug
esistance (Radford et al., 2012). The aim of the present study was  to
etermine the value of NGS in detecting putative causative agent(s)
n CSF in encephalitis.
For this purpose CSF from 60-year-old male with suspected
ncephalitis, admitted to the hospital with a 1-week history of
ever, drowsiness and severe headaches was used. These symptoms
ere preceded by a mild cold. At the time of admission the patient
as comatose with positive menigeal signs and his temperature
as 38.5 ◦C. Analysis of CSF revealed 480 leukocytes/mm3 (90%
ymphocytes), protein level of 3.21 g/l (normal value: 0.12–0.60 g/l),
nd glucose value of 2.32 mmol/l (normal value: 2.20–4.40 mmol/l).
he peripheral blood leukocyte count was 6900/mm3 with 66.7%
eutrophils and 22.2% lymphocytes. Serum and CSF samples col-
ected at admission were negative for the presence of IgM and
gG antibodies to human herpesvirus (NovaLisa HSV 1/HSV 2/HSV
 + 2 IgG/IgM ELISA; NovaTec Immundiagnostica GmBH, Dietzen-
ach, Germany). However, both anti-HHV-1 IgM and anti-HHV-1
gG were detected in subsequent CSF samples collected at 1.5, 3 and
 months. Magnetic resonance imaging (MRI) at admission showed
yperintensity in the right temporal lobe. Patient was treated with
cyclovir (Zovirax IV) for 15 days and fully recovered with no resid-
al neurological sequelae. PCR for HSV-1/2 was not performed at
dmission, as it was not a part of routine diagnostics in Poland at
hat time, and our analysis was done retrospectively.
Total RNA was isolated from 1 ml  of CSF collected at admis-
ion using the modiﬁed Chomczynski method (TRIZOL LS Reagent;
ife Technologies, Carlsbad, USA) and split into two  aliquots, one
f which (sample SDNase) was treated with DNase I (DNA-free
NA Removal Kit; Invitrogen, Waltham, USA) at a concentra-
ion of 2 U/l  for 20 min  in 37 ◦C in a ﬁnal volume of 100 l to
educe the amount of DNA present. The other aliquot remained
Nase untreated (sample S1). Control samples included HCV-RNA-
ositive serum sample adjusted to contain 100 viral copies per
eaction (sample C-HCV) and three HHV-1-negative CSF samples
samples C1–C3; Table 1).
The quantity of RNA extracted from CSF was small and was
elow the sensitivity limits of DeNovix DS-11 Spectrophotometer
DeNovix, Wilmington, USA; sensitivity ≥2 ng/l) and Qubit Fluo-
imeter (Thermo Scientiﬁc, Waltham, USA; sensitivity ≥250 pg/l).Both CSF samples (S1 and SDNAse) and all control sam-
les underwent reverse transcription followed by single-primer
sothermal ampliﬁcation (Ribo-SPIA), using commercially available
it (Ovation RNA-Seq V2 system (NuGEN, San Carlos, USA). Thegical Methods 226 (2015) 1–6
protocol closely followed manufacturer’s recommendations. The
resulting ampliﬁed ds cDNA was  puriﬁed using Agencourt AMPure
XP beads (Beckman Coulter, Pasadena, USA).
Libraries for NGS were prepared from 1 ng of ds cDNA using
Nextera XT Kit (Illumina, San Diego, USA) following manufacturer’s
protocol. First, cDNA was  fragmented using transposon-based
method followed by addition of indexes by PCR. The resulting
PCR products were puriﬁed with 1.8 volumes of AMPure XP beads
(Beckman Coulter, Pasadena, USA). The quality and average length
of sequence library for each sample was  assessed using Bioanalyzer
(Agilent Technologies, Santa Clara, USA) and either the DNA 1000 or
DNA HS kit, depending on sample concentration. The indexed sam-
ples were pooled equimolarily and sequenced on Illumina MiSeq
(150 nt, paired-end reads) in case of samples S1, SDNase, C-HCV and
on Illumina HiSeq (101 nt, paired-end reads); in case of samples
C1–C3.
Raw reads were trimmed by the following procedures: (i)
removing adaptor sequences using cutadapt-1.2.1 (Martin, 2011),
(ii) removing artifact sequences using fastx artifacts ﬁlter (http://
hannonlab.cshl.edu/fastx toolkit/index.html, 2015), and (iii) trim-
ming bases with quality below Q20 (phred quality score)
from 3′ end of each read and removing reads shorter than
50 bp using fastq quality trimmer (http://hannonlab.cshl.edu/
fastx toolkit/index.html, 2015). Trimmed sequences were then
mapped onto the human reference sequence (hg19) with the map-
ping software Stampy (Lunter and Goodson, 2011). The unmapped
sequences were subjected to similarity search using the program
blastn (Altschul et al., 1990) against the whole unﬁltered NCBI-nt
database with e-value cutoff of 1e−5. The taxonomic information of
each sequence was  assigned and the relative abundance of detected
organisms was  summarized by text mining of blastn output ﬁles
using BioRuby (Goto et al., 2010) scripts.
The initial sequencing run included samples S1, SDNase, C-HCV
and yielded 4,529,322 reads altogether. After trimming, there were
1,190,455 reads for sample S1 (no DNase treatment) and 1,030,284
reads for sample SDNase (treated with DNase I). Sequencing of
Hepatitis C Virus (HCV) positive control (sample C-HCV) provided
1,184,251 reads (Table 1). Human sequences were the most abun-
dant (43.913–99.506% of all sequences; Table 1). Viral sequences
represented 0.07–0.246% of reads and the most frequent among
them corresponded to HHV-1 (99.8% of all viral sequences in sample
S1 and 86.6% in sample SDNase). In the control HCV RNA-positive
sample 99.8% of viral reads were positively aligned to HCV genome
(Table 2). Fig. 1 shows the coverage plot of detected HHV-1 and
HCV sequences with respect to reference genomes. Importantly, the
DNase I treatment, while lowering the background of host-derived
sequences from 98.2% to 43.9%, at the same time lowered the num-
ber of detectable HHV-1 sequences by a factor of 4 (from 2579 to
629 sequences).
Control CSF samples C1–C3 were analyzed in a separate run
yielding a total of 107,219,264 reads. After trimming, there were
37,516,857 reads for sample C1, 35,638,335 reads for sample C2
and 34,064,072 reads for sample C3. The metagenomic approach
did not detect any HSV-1 sequences in any of these three samples.
The results of NGS sequencing and the most frequently identiﬁed
species/families are presented in Tables 1 and 2.
The presence of HHV-1 in CSF of the analyzed patient
was conﬁrmed by speciﬁc PCR (Fig. 2) performed as follows.
Human herpesvirus 1 (HHV-1) DNA was isolated from cere-
brospinal ﬂuid (200 l) using QIAamp DNA Mini Kit (Qiagen,
Venlo, Netherlands), then eluted in 5 l of water (Water Molec-
ular Biology Reagen; Sigma–Aldrich, Saint Louis, USA) and the
HHV speciﬁc PCR was  performed using primers speciﬁc for
both HHV-1 and HHV-2 (5′-TTGAAGCGGTCGGCGGCGTA-3′ and 5′-
GCATCGTCGAGGAGGTGGA-3′) resulting in 148 bp ampliﬁcation
product (54836 nt–54983 nt; [GenBank:NC 001806.1]). Extracted
K. Perlejewski et al. / Journal of Virological Methods 226 (2015) 1–6 3
Table  1
Next-generation sequencing (NGS) of CSF from patient with HHV-1 encephalitis and from HHV-1-negative controls. Sequences were compared to the NCBI-nt database.
Age/gender 60/male 56/female 20/female 43/female
Diagnosis HHV-1 encephalitis Encephalitis of
unknown
etiology
Encephalitis of
unknown
etiology
Multiple
sclerosis
Sample S1 SDNase C1 C2 C3 C-HCV
Total reads 1,578,856 1,427,356 37,516,857 35,638,335 34,064,072 1,523,110
Reads  after trimming 1,190,455 1,030,284 375,168,57 35,638,335 34,064,072 1,184,251
Human 1,169,244 (98.218%) 452,428 (43.913%) 36,061,952
(96.122%)
35,374,962
(99.261%)
32,616,258
(95.750%)
1,178,397 (99.506%)
Viral  2583 (0.217%) 726 (0.070%) 52,226
(0.139%)
71,493
(0.201%)
140,890
(0.414%)
2916 (0.246%)
Bacterial 5112 (0.429%) 242,633 (23.550%) 830,811
(2.215%)
120,107
(0.337%)
668,362
(1.962%)
1142 (0.096%)
Fungal  251 (0.021%) 2591 (0.251%) 45,550
(0.121%)
3190 (0.009%) 78,112
(0.229%)
32 (0.003%)
Protozoan 22 (0.002%) 795 (0.077%) 6386 (0.017%) 1100 (0.003%) 16,298
(0.048%)
13 (0.001%)
Othera 12,018 (1.010%) 315,615 (30.634%) 428,866
(1.143%)
36,106
(0.104%)
468,183
(1.374%)
1015 (0.086%)
No  match 1225 (0.103%) 15,496 (1.504%) 91,066
(0.243%)
31,377
(0.088%)
75,969
(0.223%)
736 (0.062%)
S1, no DNase I treatment; SDNase, treated with DNase I; C, HCV-RNA positive serum.
Samples C1–C3 were negative for HHV-1 by PCR.
a Sequences related to plants, plant viruses, synthetic constructs.
Table 2
The most frequently identiﬁed species/families in cerebrospinal ﬂuid from a patient with HHV-1 encephalitis and controls.
Viruses Bacteriaa Fungia Protozoa
S1 Human
herpesvirus 1
(2579)
Inﬂuenza C
virus (3)
Hepatitis C
virus (1)
Moraxellaceae (871)
Micrococcaceae (554)
Corynebacteriaceae (321)
Propionibacteriaceae (204)
Gordoniaceae (206)
Pyrenophora teres (151)
Pyrenophora tritici-repentis (29)
Malassezia sympodialis (14)
Malassezia globosa (10)
Debaryomyces hansenii (7)
–
SDNase Human
herpesvirus 1
(629)
Inﬂuenza C
virus (55)
Hepatitis C
virus (39)
Moraxellaceae (37,130)
Staphylococcaceae (35,753)
Micrococcaceae (48,011)
Corynebacteriaceae (19,993)
Neisseriaceae (8240)
Uncultured fungus (519)
Uncultured Cryptococcus (206)
Uncultured Rhodotorula (180)
Malassezia sympodialis (142)
Malassezia globosa (147)
Albugo laibachii (441)
Besnoitia besnoiti (89)
Trypanoplasma borreli (83)
Ichthyophthirius multiﬁliis
(75)
C1  – Corynebacteriaceae (2,75,825)
Staphylococcaceae (93,611)
Micrococcaceae (73,191)
Moraxellaceae (51,378)
Sphingobacteriaceae (29,855)
Uncultured fungus (10,062)
Pseudogymnoascus destructans
(1199)
Melampsora larici-populina
(995)
Leucosporidium sp. AY30 (787)
Uncultured soil fungus (786)
Nannochloropsis oceanica
(1549)
Albugo laibachii (401)
Amphiﬁlidae sp. H-1 (373)
Babesia divergens (371)
Exocolpoda augustini (324)
C2  – Burkholderiaceae (40,597)
Sphingobacteriaceae (30,089)
Streptococcaceae (5702)
Bradyrhizobiaceae (4649)
Enterobacteriaceae (4546)
Uncultured fungus (551)
Geotrichum klebahnii (250)
Malassezia globosa (225)
Dipodascus tetrasporeus (132)
Mortierella alpina (82)
Nannochloropsis oceanica
(3204)
Plasmodium ovale (1201)
Albugo laibachii (964)
Babesia divergens (549)
Plasmodium inui (312)
C3  – Moraxellaceae (94,524)
Enterobacteriaceae (67,339)
Corynebacteriaceae (59,747)
Micrococcaceae (48,846)
Bradyrhizobiaceae (47,559)
Uncultured fungus (12,841)
Triposporium cycadicola (4346)
Mollisina uncinata (3997)
Pseudogymnoascus destructans
(2790)
Melampsora larici-populina
(2465)
Nannochloropsis oceanica
(2468)
Albugo laibachii (2274)
Plasmodium inui (2075)
Eunotia sp. ECR-2014
(1780)
Plasmodium vinckei (588)
C-HCV  Hepatitis C
virus (2905)
Inﬂuenza C
virus (3)
Moraxellaceae (197)
Micrococcaceae (166)
Propionibacteriaceae (67)
Streptococcaceae (66)
Comamonadaceae (62)
Debaryomyces hansenii (19)
Staninwardia suttonii (2)
Malassezia sympodialis (2)
Leptosphaeria maculans (2)
Entyloma calendulae (2)
–
S1, no DNase I treatment; SDNase, treated with DNase I; C-HCV, HCV-RNA positive serum; C1 and C2, CSF of patients with encephalitis of unknown etiology; C3, CSF of patient
with  multiple sclerosis.
Samples C1–C3 were negative for HHV-1 by PCR.
The numbers of sequences representing each species/family are shown in brackets.
a 5 most numerous families.
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Fig. 1. Coverage plot of HHV-1 and HCV genomes. Sequencing reads from samples S1 a
number  AB618031) and control sample C-HCV was  mapped to HCV genome (GenBank ac
Fig. 2. PCR detection of human herpesvirus type 1 (HHV-1). Lane: 1, CSF sample
drawn at admission; 2, positive control (400 target copies of HHV-1 DNA from HHV-
1
L
w
D
C
(
a
′ infected Vero cells 3, negative control consisting of water; M,  GeneRuler 50 bp DNA
adder (Feremntas, Thermo Scientiﬁc, Waltham, USA; 50 bp). Expected product size
as  148 bp.NA (38 l) was mixed with 5 l of 10× buffer (Life Technologies,
arlsbad, USA), 2 l of PCR primers (10 M),  2 l of 50× dNTP
10 mM),  5 l of 25 mM MgCl2 (Life Technologies, Carlsbad, USA)
nd 2.5 U of Taq Polymerase (Life Technologies, Carlsbad, USA) innd SDNase were mapped to the reference genome of HHV-1 (GenBank accession
cession number EF407475).
ﬁnal volume of 50 l. After the initial 5 min  denaturation in 94 ◦C, 50
cycles of 94 ◦C for 30 s and 68 ◦C for 30 s were run using thermocy-
cler 9700 Applied Biosystem (Applied Biosystem, Life Technologies,
Carlsbad, USA). PCR products were analyzed by electrophoresis in
2% agarose. Detection limit of our PCR was  ≥44 viral copies per reac-
tion. PCR sensitivity was  determined using serial dilutions of DNA
extracted from HHV-1 infected Vero cell culture (Virus Isolation and
Reference Service Laboratory, New York State Health Department).
In the present study we unexpectedly detected HHV-1, which is
a DNA virus, while analyzing CSF sample subjected to RNA extrac-
tion by the most widely used Chmoczynski method followed by
RNA ampliﬁcation. This ﬁnding could have been the result of viral
mRNA detection, or alternatively, a substantial quantity of DNA
could have been retained after RNA extraction, thus allowing for
the detection of both RNA and DNA sequences. To verify the latter
possibility, serial 10-fold dilutions of plasmid template (pCR2.1-
TOPO, Invitrogen, Waltham, USA) were spiked into CSF sample
from an uninfected patient and subjected to parallel RNA and DNA
extractions (TRIZOL LS Reagent, Life Technologies and QIAamp DNA
Mini Kit, Qiagen, Venlo, Netherlands). Genetic material extracted
from each sample was subjected to real-time PCR (10 min dena-
turation in 95 ◦C followed by 55 cycles of 95 ◦C for 10 s and 50 ◦C
for 15 s) using LightCycler FastStart DNA Master SYBR Green I
(Roche Molecular Diagnostics, Basel, Switzerland) and primers (5 -
GTAAAACGACGGCCAG-3′; 5′-CAGGAAACAGCTATGAC-3′) resulting
in 202 bp ampliﬁcation product. As seen in Fig. 3, RNA extrac-
tion retained a signiﬁcant amount of DNA which was sufﬁcient for
K. Perlejewski et al. / Journal of Virological Methods 226 (2015) 1–6 5
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(ig. 3. Real-time PCR detection of serial 10-fold dilutions of plasmid template (pCR2
ere  either extracted for DNA (D), or RNA (R). Samples 1, 2, 3, 4 contained 103, 104
eal-time PCR detection of ≥103 plasmid copies. Surprisingly, for
 wide range of plasmid concentrations tested (103, 104, 105 and
06 per reaction) the RNA extraction resulted in only 1.6–3.1 fold
ensitivity decrease when compared to DNA extraction.
Determining the etiology of encephalitis remains challenging
n clinical practice, partly due to the sheer number of potential
athogens. So far over 100 viruses were reported to be capable
f causing encephalitis, and this number is still growing (Debiasi
nd Tyler, 2004). The results of some recent studies indicate that
igh-throughput sequencing could be successfully used to identify
ausative pathogens in patients with central nervous system infec-
ions. For example, Chan et al. (2014) identiﬁed measles virus and
HV-1 in frozen brain tissue samples using Illumina HiSeq 2000,
hereas Tan le et al. (2013) used FLX genome sequencer (454 Life
cience, Roche) and Wilson et al. (2014) used Illumina MiSeq to
etect Cyclovirus and Leptospira sanatarosa in CSF, respectively.
oreover, NGS based approaches enable identiﬁcation of all agents
n a single run, regardless whether their sequence is known, or not
Big et al., 2009; Dupuis et al., 2011; Glaser et al., 2006; Quan et al.,
010).
Our approach, which employed NuGen Ribo-SPIA followed by
GS and metagenomic data analysis, led to the identiﬁcation of
HV-1 in CSF from a patient with acute encephalitis at a time when
peciﬁc antibodies could not yet be detected. Subsequently, the
tiology of encephalitis was conﬁrmed by speciﬁc PCR as well as
HV-1 seroconversion in the follow up CSF samples.
Host-derived genetic material is commonly present in clini-
al samples and presents a major challenge for NGS analysis (Lim
t al., 2013). A commonly used method to reduce human genetic
ackground is DNase I treatment of the samples (Allander et al.,
001). While we found that this approach would result in more
han two fold decrease in the number of host-derived sequences, it
igniﬁcantly (30–50 fold) increased the number of bacterial and
other” sequences probably because of diminished competition
rom human DNA. Not unexpectedly, the use of DNase I resulted
lso in the reduction of HHV-1 sequences.
Interestingly, samples provided a signiﬁcant number of bacterial
eads and sequences classiﬁed as other (plants, plant viruses). This
roblem was previously reported for other NGS studies (Bzhalava
t al., 2012; Salter et al., 2014). Bacterial contamination is often
ound in existing human-derived RNA sequence datasets and will
emain an important issue for future NGS diagnostic application
Laurence et al., 2014; Strong et al., 2014). The presence of HCVPO; Invitrogen, Waltham, USA) spiked into CSF from an uninfected patient. Samples
nd 106 plasmid copies per reaction, respectively.
sequences in analyzed CSF samples was most likely the result of
index mis-assign in Illumina sequencing (Kircher et al., 2012) and
the second independent run with three HHV-1 negative control CSF
samples revealed neither HCV nor HHV-1 sequences. Intriguing,
samples from the ﬁrst run contained a small number of inﬂuenza C
sequences, which raises the question of their origin. However, the
analysis was conducted on the peak of ﬂu season (end of February)
and it is currently almost impossible to completely eliminate envi-
ronmental contaminants during library preparation process and
mis-assigned reads from other samples.
Surprisingly, we  detected HHV-1 genetic material in CSF which
was extracted for RNA and similar occurrence has been reported
by Chan et al. (2014). Modiﬁed acid guanidinium thiocyanate-
phenol-chloroform RNA extraction is known to generate genomic
DNA contaminants (Siebert and Chenchik, 1993) and in our study
signiﬁcant DNA presence after RNA extraction was  conﬁrmed by
quantitative analysis of plasmid template.
In conclusions, it seems that NGS, when necessary preceded by
unspeciﬁc nucleic acid ampliﬁcation, could supplement currently
used diagnostic methods for the determination of encephalitis
etiology. However, due to common index mis-assignment and con-
tamination with reagents-derived nucleic acids, the presence of any
identiﬁed pathogen should be veriﬁed by PCR or culture. We  also
found that extraction of total RNA could be used for the identiﬁca-
tion of both DNA and RNA pathogens in a single run.
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